tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
TransMedics Group’s OCS Lung: A Game-Changer in Organ Care with Promising Clinical Advancements
PremiumRatingsTransMedics Group’s OCS Lung: A Game-Changer in Organ Care with Promising Clinical Advancements
1M ago
TransMedics Group: Strong Performance and Strategic Initiatives Drive Buy Rating
Premium
Ratings
TransMedics Group: Strong Performance and Strategic Initiatives Drive Buy Rating
1M ago
TransMedics Group’s Strategic Advancements and FDA Approval Drive Buy Rating
Premium
Ratings
TransMedics Group’s Strategic Advancements and FDA Approval Drive Buy Rating
1M ago
TransMedics Group: Strong Financial Performance and Optimistic Outlook Justify Buy Rating
PremiumRatingsTransMedics Group: Strong Financial Performance and Optimistic Outlook Justify Buy Rating
2M ago
TransMedics reports Q2 EPS 92c vs. 35c last year
Premium
The Fly
TransMedics reports Q2 EPS 92c vs. 35c last year
2M ago
TransMedics raises FY25 revenue view to $585M-$605M from $565M-$585M
Premium
The Fly
TransMedics raises FY25 revenue view to $585M-$605M from $565M-$585M
2M ago
Strong Financial Outlook: TransMedics Group’s Surpassing Sales and EPS Forecasts
PremiumRatingsStrong Financial Outlook: TransMedics Group’s Surpassing Sales and EPS Forecasts
2M ago
TransMedics Group: Strong Growth in Organ Care and Aviation Services Justifies Buy Rating
Premium
Ratings
TransMedics Group: Strong Growth in Organ Care and Aviation Services Justifies Buy Rating
2M ago
TransMedics Group: Hold Rating Amid Ambiguous Job Posting Trends
Premium
Ratings
TransMedics Group: Hold Rating Amid Ambiguous Job Posting Trends
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100